Ardelyx Cash on Hand 2013-2025 | ARDX

Ardelyx cash on hand from 2013 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Ardelyx Annual Cash on Hand
(Millions of US $)
2024 $250
2023 $184
2022 $124
2021 $117
2020 $186
2019 $248
2018 $168
2017 $134
2016 $201
2015 $107
2014 $107
2013 $34
2012 $33
Ardelyx Quarterly Cash on Hand
(Millions of US $)
2025-09-30 $243
2025-06-30 $238
2025-03-31 $214
2024-12-31 $250
2024-09-30 $190
2024-06-30 $186
2024-03-31 $203
2023-12-31 $184
2023-09-30 $165
2023-06-30 $128
2023-03-31 $130
2022-12-31 $124
2022-09-30 $91
2022-06-30 $81
2022-03-31 $90
2021-12-31 $117
2021-09-30 $142
2021-06-30 $172
2021-03-31 $178
2020-12-31 $186
2020-09-30 $185
2020-06-30 $205
2020-03-31 $223
2019-12-31 $248
2019-09-30 $104
2019-06-30 $124
2019-03-31 $152
2018-12-31 $168
2018-09-30 $186
2018-06-30 $213
2018-03-31 $127
2017-12-31 $134
2017-09-30 $129
2017-06-30 $149
2017-03-31 $173
2016-12-31 $201
2016-09-30 $230
2016-06-30 $147
2016-03-31 $172
2015-12-31 $107
2015-09-30 $129
2015-06-30 $142
2015-03-31 $98
2014-12-31 $107
2014-09-30 $112
2014-06-30 $118
2014-03-31 $33
2013-12-31 $34
2013-09-30
2013-06-30
2013-03-31
2012-12-31 $33
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.881B $0.334B
Ardelyx, Inc. is a clinical-stage biopharmaceutical company. It discovers, develops and commercializes small molecule therapeutics that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases. The Company's lead product candidate is Tenapanor which is in three ongoing Phase II clinical trials for the treatment of patients with ESRD-HD and chronic kidney disease, as well as for constipation-predominant irritable bowel syndrome. Ardelyx, Inc. is headquartered in Fremont, California.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $89.187B 33.88
Zoetis (ZTS) United States $56.043B 20.06
Takeda Pharmaceutical (TAK) Japan $51.898B 10.59
Daiichi Sankyo, - (DSNKY) Japan $43.551B 21.69
BeOne Medicines - (ONC) Switzerland $37.054B 196.45
Sandoz Group AG (SDZNY) Switzerland $33.348B 0.00
United Therapeutics (UTHR) United States $20.806B 18.31
Merck (MKKGY) Germany $19.348B 11.93
Shionogi (SGIOY) Japan $15.738B 14.45
Summit Therapeutics (SMMT) United States $15.176B 0.00
Neurocrine Biosciences (NBIX) United States $13.539B 32.49
Ionis Pharmaceuticals (IONS) United States $13.007B 0.00
IPSEN (IPSEY) France $12.338B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.675B 0.00
Orion OYJ (ORINY) Finland $11.045B 31.56
Eisai (ESAIY) $8.854B 0.00
Ono Pharmaceutical (OPHLF) Japan $6.576B 20.00
Grifols, S.A (GRFS) Spain $6.442B 0.00
Stevanato Group S.p.A (STVN) Italy $6.378B 35.69
Crinetics Pharmaceuticals (CRNX) United States $5.053B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.613B 0.00
Indivior (INDV) United States $4.431B 18.08
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.074B 19.34
Corcept Therapeutics (CORT) United States $3.945B 42.61
NewAmsterdam Pharma (NAMS) Netherlands $3.897B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $3.014B 0.00
Hypermarcas (HYPMY) Brazil $2.914B 20.00
Catalyst Pharmaceuticals (CPRX) United States $2.793B 8.91
Dyne Therapeutics (DYN) United States $2.538B 0.00
Ocular Therapeutix (OCUL) United States $2.399B 0.00
Soleno Therapeutics (SLNO) United States $2.310B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.100B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.997B 23.67
Guardian Pharmacy Services (GRDN) United States $1.920B 36.98
Harrow (HROW) United States $1.733B 106.32
BioCryst Pharmaceuticals (BCRX) United States $1.559B 92.50
Enliven Therapeutics (ELVN) United States $1.543B 0.00
Collegium Pharmaceutical (COLL) United States $1.440B 7.13
Relay Therapeutics (RLAY) United States $1.385B 0.00
Oruka Therapeutics (ORKA) United States $1.349B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.341B 0.00
Xeris Biopharma Holdings (XERS) United States $1.316B 0.00
Evotec AG (EVO) Germany $1.300B 0.00
ARS Pharmaceuticals (SPRY) United States $1.291B 0.00
Savara (SVRA) United States $1.182B 0.00
Cronos Group (CRON) Canada $1.025B 0.00
Xencor (XNCR) United States $0.992B 0.00
Theravance Biopharma (TBPH) United States $0.965B 40.51
Esperion Therapeutics (ESPR) United States $0.928B 0.00
KalVista Pharmaceuticals (KALV) United States $0.849B 0.00
Nektar Therapeutics (NKTR) United States $0.808B 0.00
Lexeo Therapeutics (LXEO) United States $0.769B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.741B 6.62
ProKidney (PROK) United States $0.704B 0.00
Bioventus (BVS) United States $0.665B 13.61
Ironwood Pharmaceuticals (IRWD) United States $0.660B 15.61
Organogenesis (ORGO) United States $0.534B 0.00
Lyell Immunopharma (LYEL) United States $0.522B 0.00
Elite Pharmaceuticals (ELTP) United States $0.521B 0.00
Zevra Therapeutics (ZVRA) United States $0.478B 0.00
Aquestive Therapeutics (AQST) United States $0.477B 0.00
Siga Technologies (SIGA) United States $0.473B 6.48
4D Molecular Therapeutics (FDMT) United States $0.429B 0.00
Altimmune (ALT) United States $0.419B 0.00
Akebia Therapeutics (AKBA) United States $0.403B 0.00
Nature's Sunshine Products (NATR) United States $0.380B 22.64
USANA Health Sciences (USNA) United States $0.363B 10.13
Relmada Therapeutics (RLMD) United States $0.316B 0.00
Avalo Therapeutics (AVTX) United States $0.314B 0.00
Profound Medical (PROF) Canada $0.306B 0.00
Protara Therapeutics (TARA) United States $0.297B 0.00
Achieve Life Sciences (ACHV) Canada $0.296B 0.00
Aclaris Therapeutics (ACRS) United States $0.286B 0.00
Larimar Therapeutics (LRMR) United States $0.276B 0.00
OmniAb (OABI) United States $0.275B 0.00
Fractyl Health (GUTS) United States $0.274B 0.00
Silence Therapeutics (SLN) United Kingdom $0.261B 0.00
Heron Therapeutics (HRTX) United States $0.255B 0.00
Aldeyra Therapeutics (ALDX) United States $0.247B 0.00
Enlivex Therapeutics (ENLV) Israel $0.214B 0.00
MediWound (MDWD) Israel $0.207B 0.00
Galectin Therapeutics (GALT) United States $0.203B 0.00
Journey Medical (DERM) United States $0.197B 0.00
Minerva Neurosciences (NERV) United States $0.193B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.188B 0.00
Innate Pharma SA (IPHYF) France $0.181B 0.00
Century Therapeutics (IPSC) United States $0.170B 0.00
Prelude Therapeutics (PRLD) United States $0.165B 0.00
VAXART, INC (VXRT) United States $0.164B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.161B 0.00
AleAnna (ANNA) United States $0.160B 0.00
Karyopharm Therapeutics (KPTI) United States $0.159B 0.00
Surrozen (SRZN) United States $0.158B 0.00
Context Therapeutics (CNTX) United States $0.148B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.146B 0.00
Incannex Healthcare (IXHL) Australia $0.137B 0.00
Unicycive Therapeutics (UNCY) United States $0.133B 0.00
Inhibikase Therapeutics (IKT) United States $0.129B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.127B 0.00
Pyxis Oncology (PYXS) United States $0.110B 0.00
Avita Medical (RCEL) United States $0.104B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Cardiol Therapeutics (CRDL) Canada $0.099B 0.00
Vivani Medical (VANI) United States $0.097B 0.00
Champions Oncology (CSBR) United States $0.094B 39.88
Korro Bio (KRRO) United States $0.089B 0.00
Gain Therapeutics (GANX) United States $0.089B 0.00
Plus Therapeutics (PSTV) United States $0.076B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.074B 61.88
PolyPid (PYPD) Israel $0.074B 0.00
Dominari Holdings (DOMH) United States $0.068B 0.00
Metagenomi (MGX) United States $0.067B 0.00
Rafael Holdings (RFL) United States $0.066B 0.00
NRx Pharmaceuticals (NRXP) United States $0.066B 0.00
Arch Biopartners (ACHFF) Canada $0.064B 0.00
PMV Pharmaceuticals (PMVP) United States $0.063B 0.00
Assertio Holdings (ASRT) United States $0.059B 0.00
Acrivon Therapeutics (ACRV) United States $0.055B 0.00
Lite Strategy (LITS) United States $0.054B 0.00
Nutriband (NTRB) United States $0.053B 0.00
Talphera (TLPH) United States $0.049B 0.00
Telomir Pharmaceuticals (TELO) United States $0.047B 0.00
ElectroCore (ECOR) United States $0.045B 0.00
Lipocine (LPCN) United States $0.044B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.039B 0.00
FibroGen (KYNB) United States $0.037B 0.00
Jupiter Neurosciences (JUNS) United States $0.036B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Wellgistics Health (WGRX) United States $0.035B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.033B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Natural Alternatives (NAII) United States $0.028B 0.00
TherapeuticsMD (TXMD) United States $0.025B 0.00
Klotho Neurosciences (KLTO) United States $0.025B 0.00
Scienture Holdings (SCNX) United States $0.023B 0.00
Inotiv (NOTV) United States $0.021B 0.00
Cosmos Health (COSM) United States $0.021B 0.00
Liminatus Pharma (LIMN) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
Vyome Holdings (HIND) United States $0.018B 0.00
China SXT Pharmaceuticals (SXTC) China $0.018B 0.00
Iterum Therapeutics (ITRM) Ireland $0.017B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Tempest Therapeutics (TPST) United States $0.014B 0.00
CASI Pharmaceuticals (CASI) China $0.014B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Traws Pharma (TRAW) United States $0.011B 0.01
Curanex Pharmaceuticals Inc (CURX) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
BioVie (BIVI) United States $0.010B 0.00
Ainos (AIMD) United States $0.009B 0.00
Nuvilex (PMCB) United States $0.009B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Heatwurx (PCSA) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Redhill Biopharma (RDHL) Israel $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Salarius Pharmaceuticals (DCOY) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
CDT Equity (CDT) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00